top of page

Bionote USA Partners with MWI Animal Health

Bionote, USA

Vcheck Line of In-Clinic Diagnostic Analyzers, Quantitative Biomarker Tests

and New CHW One-Step Rapid Test Now Available Through MWI

 

BIG LAKE, MINN. (July 30, 2024)  Bionote USA announces its partnership with MWI Animal Health (MWI) for the distribution of Bionote products including the Vcheck line of quantitative, in-clinic analyzers and biomarker tests and its new standalone, one-step rapid test for detecting Canine Heartworm.

 

MWI’s extensive nationwide distribution networks allow the company to provide high-efficiency order fulfillment and next-day delivery of veterinary equipment and supplies across the U.S. Their ability to work closely with and provide a variety of options for their veterinary clients demonstrates how MWI is in the dynamic position to connect veterinary providers with the best equipment solutions and products.


Bionote’s Vcheck V200 and V2400 analyzers (also known as the Vcheck F series) are the only in-clinic immunofluorescence assay analyzers to use cutting-edge europium technology, which has proven to be more specific than colloidal gold material. This advanced technology, along with affordable pricing on analyzers and tests, positions Bionote to be an essential provider of in-clinic diagnostic tools for practices throughout the country.


The analyzers deliver quantitative results in minutes for any of Bionote’s 17 Vcheck tests, covering canine, feline and equine biomarkers. This includes industry-exclusive canine and feline NT-proBNP and Troponin I. Bionote also now offers a Canine Heartworm (CHW) rapid test that indicates heartworm presence in just one step without the need for any analyzers or additional equipment such as a buffer solution. Many of these tests have been verified by Bionote to be specific and accurate with university-validated studies.

 

“MWI strives to make the lives of veterinarians easier, giving them the freedom to practice medicine with products that fit their needs and budget. This approach is something we identify with, as the Vcheck line was developed to reduce the time and cost needed for diagnostic testing,” said Randy Knick, president of Bionote USA.

 

To learn more about the Vcheck line and Bionote USA, visit www.bionote.com. More information about MWI can be found at www.mwiah.com.


Comments


Commenting has been turned off.
bottom of page